Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. BBBY
BBBY logo

BBBY Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Bed Bath & Beyond Inc (BBBY) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
5.300
1 Day change
-1.12%
52 Week Range
12.650
Analysis Updated At
2026/05/08
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.
Sign Up

BBBY is not a good buy right now for a beginner long-term investor, even with $50,000-$100,000 to invest. The stock has some positive strategic and sentiment catalysts, but the chart is still weak and the latest quarter shows profitability pressure. For a patient long-term buyer, this looks more like a wait-and-watch name than an immediate purchase.

Technical Analysis

The short-term trend is mixed to bearish. MACD histogram is below zero, indicating weak momentum, though it is slightly contracting, which suggests selling pressure is easing. RSI at 55.5 is neutral, so the stock is not oversold or showing a strong breakout setup. The moving average structure is bearish with SMA_200 > SMA_20 > SMA_5, which confirms the broader trend is still under pressure. Price at 5.26 is below the pivot level of 5.836 and closer to support at 4.667 than resistance at 7.005. The candlestick-based model suggests modest upside over the next month, but not enough to override the weaker trend structure.

Options Data

Bullish
Open Interest Put-Call Ratio
Bullish
Option Volume Put-Call Ratio

Options sentiment is bullish overall. The low put-call ratios show more call activity than put activity, suggesting traders are leaning positive. Open interest and volume are both call-heavy, which supports a constructive near-term sentiment. IV is moderately elevated but not extreme, and volume is running above recent averages, so options traders are active and mildly optimistic.

Technical Summary

StrongSellSellNeutralBuyStrongBuydotted line Image
Sell
5
Buy
5

Positive Catalysts

    • Wedbush raised its price target to $8 and kept an Outperform rating.
    • Wedbush said the company posted its first quarter of meaningful year-over-year growth since restructuring began, which supports the stabilization story.
    • Amplify Investment disclosed an 8.7% passive stake and increased ownership, signaling outside confidence.
    • Recent revenue growth in Q1 shows top-line traction is improving.
    • Options sentiment is strongly call-biased, which reflects bullish trader positioning.

Neutral/Negative Catalysts

    • The stock is still in a bearish moving-average structure.
    • MACD remains negative, showing momentum has not fully turned positive.
    • Net income and EPS declined sharply year over year in the latest quarter.
    • Gross margin also fell year over year, showing profitability pressure.
    • Piper Sandler kept only a Neutral rating and cut its price target earlier, reflecting ongoing uncertainty.
    • Hedge funds and insiders are both neutral, so there is no strong smart-money accumulation signal.

Financial Performance

In Q1 2026, revenue increased 6.91% year over year to 247.8 million, which is the clearest sign of improving business momentum. However, profitability weakened: net income fell to -16.4 million, EPS dropped to -0.24, and gross margin declined to 23.89%. This means the company is growing sales, but the latest quarter still shows that earnings quality and margin recovery remain incomplete.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

Analyst sentiment has improved slightly but remains mixed. Wedbush raised its target to $8 from $7 and kept an Outperform rating, citing meaningful year-over-year growth and improving website trends. Piper Sandler previously lowered its target to $8 from $10 and stayed Neutral, pointing to sequential improvement but continued uncertainty. Overall, Wall Street sees a possible recovery story, but the pros are not fully aligned yet; the bullish case is still stronger than the bearish case, though not strong enough for an immediate long-term buy.

Wall Street analysts forecast BBBY stock price to rise
5 Analyst Rating
Wall Street analysts forecast BBBY stock price to rise
1 Buy
4 Hold
0 Sell
Hold
Current: 5.360
sliders
Low
8
Averages
11.67
High
17
Current: 5.360
sliders
Low
8
Averages
11.67
High
17
Wedbush
NULL
to
Outperform
maintain
$7 -> $8
AI Analysis
2026-04-28
Reason
Wedbush
Price Target
$7 -> $8
AI Analysis
2026-04-28
maintain
NULL
to
Outperform
Reason
Wedbush raised the firm's price target on Bed Bath & Beyond to $8 from $7 and keeps an Outperform rating on the shares. The firm notes Bed Bath & Beyond reported the first quarter of meaningful year-over-year growth since the restructuring program began, confirming that the core stabilization narrative is now translating into top-line traction. Now the company looks to turbocharge growth and margins by integrating and revitalizing its new home assets into a broader home solutions platform. Wedbush expects at least $40M in annualized cost savings and productivity efficiencies within 12-18 months of full integration.
Piper Sandler
Neutral
downgrade
$10 -> $8
2026-02-24
Reason
Piper Sandler
Price Target
$10 -> $8
2026-02-24
downgrade
Neutral
Reason
Piper Sandler lowered the firm's price target on Bed Bath & Beyond to $8 from $10 and kept a Neutral rating on the shares following a Q4 print that showed sequential improvement in the core business. While revenue was still down year-over-year, internal initiatives such as SKU consolidation appear to be gaining traction, Piper notes. The firm remains on the sidelines given the amount of uncertainty in bringing its three-pillar framework together.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for BBBY
Unlock Now

People Also Watch